Compared to controls, postmenopausal patients with BC had significant estrogen-independent associations with the IgA+/IgA− gut microbiota, suggesting that the gut microbiome may influence the BC risk by altered metabolism, estrogen recycling, and immune pathway (42). This evidence concerns the gene CD79A and breast cancer.